Under hypoxia, the expression of ADAM-17 driven by metastatic breast cancer stem cells (mBCSCs) leads to the shedding of the extracellular domain of nectin-4 into the microenvironment and interacts with integrin β4 in the microenvironment. The gene discussed is NECTIN4; the disease is breast carcinoma.